Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer

Muti Paola; Secreto Giorgio; Krogh Vittorio

首页> 外文期刊>Breast cancer research and treatment. >Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer

【24h】

Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer

机译：卵巢抑制在早期乳腺癌前进妇女的联合内分泌辅助治疗中的卵巢抑制

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Breast cancer research and treatment.》 |2017年第3期|共2页
作者
Muti Paola; Secreto Giorgio; Krogh Vittorio;
展开▼
作者单位

McMaster Univ Dept Oncol Fac Hlth Sci 711 Concession St G 60 Wing 1st Floor Room 125 Hamilton;

Fdn Ist Nazl Tumori Milano Milan Italy;

Fdn Ist Nazl Tumori Milano Milan Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer [J] . Muti Paola, Secreto Giorgio, Krogh Vittorio Breast cancer research and treatment. . 2017,第3期

机译：卵巢抑制在早期乳腺癌前进妇女的联合内分泌辅助治疗中的卵巢抑制
2. Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12 [J] . Gnant M., Mlineritsch B., Stoeger H., Annals of oncology: official journal of the European Society for Medical Oncology . 2015,第2期

机译：唑来膦酸联合他莫昔芬与阿那曲唑联合辅助内分泌治疗对绝经前早期乳腺癌的卵巢功能抑制：奥地利乳腺癌和结直肠癌研究组试验的最终分析12
3. Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative Tumors [J] . Conforti Fabio, Pala Laura Journal of Clinical Oncology . 2019,第21期

机译：Exemestane plus卵巢功能抑制是患有内分泌响应乳腺癌的最佳辅助治疗的最佳辅助治疗较高的复发风险和Her2阴性肿瘤
4. Association of bone mineral density and mammographic breast density in premenopausal and postmenopausal Malaysian women: Study on women with and without breast cancer [C] . Norhayati Mohd Zain, Vengkatha Priya Seriramulu, Kanaga Kumari Chelliah, International Conference on Bio-engineering for Smart Technologies . 2016

机译：绝经前和绝经后马来西亚女性的骨矿物质密度与乳房X线照片乳房密度的关系：有无乳腺癌的女性研究
5. Adherence to Adjuvant Endocrine Therapy among Women Diagnosed with Early Breast Cancer. [D] . Farias, Albert. 2015

机译：在诊断为早期乳腺癌的女性中坚持辅助内分泌治疗。
6. Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative Tumors [O] . Fabio Conforti, Laura Pala -1

机译：Exemestane加卵巢功能抑制是绝经前妇女的最佳辅助治疗该绝经前妇女患有内分泌反应性乳腺癌且复发风险较高且HER2阴性肿瘤。
7. Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT [O] . M.M. Regan, B.A. Walley, P.A. Francis, 2017

机译：卵巢函数抑制与内分泌症患者高乳腺癌化疗的同时和顺序启动卵巢功能抑制：文本和柔软的探索性分析
8. Use of a Cognitive Protectant to Help Maintain Quality of Life and Cognition in Premenopausal Women with Breast Cancer Undergoing Adjuvant Chemotherapy [R] . Klemp, J. R. 2006

机译：使用认知保护剂帮助维持乳腺癌辅助化疗的绝经前妇女的生活质量和认知能力

Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer

著录项

相似文献

相关主题

期刊订阅